Aviva UK: Morgan Stanley European Financials Conference, March 2011

download Aviva UK: Morgan Stanley European Financials Conference, March 2011

of 17

Transcript of Aviva UK: Morgan Stanley European Financials Conference, March 2011

  • 8/7/2019 Aviva UK: Morgan Stanley European Financials Conference, March 2011

    1/17

    Morgan StanleyEuropean Financials Conference

    31 March 2011

  • 8/7/2019 Aviva UK: Morgan Stanley European Financials Conference, March 2011

    2/17

    Disclaimer

    Cautionary statements:

    This should be read in conjunction with the documents filed by Aviva plc (the Company or Aviva) with the United States Se curities and Exchange

    Commission (SEC). This announcement contains, and we may make verbal statements containing, forward-looking statements with respect to certain

    of Avivas plans and current goals and expectations relating to future financial condition, performance, results, strategic i nitiatives and objectives.

    Statements containing the words believes, intends, expects, plans, will, seeks, aims, may, could, outlook, estimates and anticipates,

    and words of similar meaning, are forward-looking. By their nature, all forward-looking statements involve risk and uncertainty. Accordingly, there are or

    will be important factors that could cause actual results to differ materially from those indicated in these statements. Aviva believes factors that could

    cause actual results to differ materially from those indicated in forward-looking statements in the presentation include, but are not limited to: the impact of

    difficult conditions in the global capital markets and the economy generally; the impact of new government initiatives related to the financial crisis; defaults

    and impairments in our bond, mortgage and structured credit portfolios; changes in general economic conditions, including foreign currency exchange

    rates, interest rates and other factors that could affect our profitability; the impact of volatility in the equity, capital and credit markets on our profitabilityand ability to access capital and credit; risks associated with arrangements with third parties, including joint ventures; inability of reinsurers to meet

    obligations or unavailability of reinsurance coverage; a decline in our ratings with Standard & Poors, Moodys, Fitch and A. M. Best; increased competition

    in the U.K. and in other countries where we have significant operations; changes to our brands and reputation; changes in assumptions in pricing and

    reserving for insurance business (particularly with regard to mortality and morbidity trends, lapse rates and policy renewal rates), longevity and

    endowments; a cyclical downturn of the insurance industry; changes in local political, regulatory and economic conditions, business risks and challenges

    which may impact demand for our products, our investment portfolio and credit quality of counterparties; the impact of actual experience differing from

    estimates on amortisation of deferred acquisition costs and acquired value of in-force business; the impact of recognising an impairment of our goodwill or

    intangibles with indefinite lives; changes in valuation methodologies, estimates and assumptions used in the valuation of investment securities; the effect

    of various legal proceedings and regulatory investigations; the impact of operational risks; the loss of key personnel; the impact of catastrophic events on

    our results; changes in government regulations or tax laws in jurisdictions where we conduct business; funding risks associated with our pensionschemes; the effect of undisclosed liabilities, integration issues and other risks associated with our acquisitions; and the timing impact and other

    uncertainties relating to acquisitions and disposals and relating to other future acquisitions, combinations or disposals within relevant industries. For a

    more detailed description of these risks, uncertainties and other factors, please see Item 3, Risk Factors, and Item 5, Op erating and Financial Review

    and Prospects in Avivas Annual Report Form 20-F as filed with the SEC on 24 March 2011. Aviva undertakes no obligation to update the forward

    looking statements in this announcement or any other forward-looking statements we may make. Forward-looking statements in this presentation are

    current only as of the date on which such statements are made.

    2

  • 8/7/2019 Aviva UK: Morgan Stanley European Financials Conference, March 2011

    3/17

    Resilient & diversified with growing earnings

    Delivering against the targets

    At least 1.5 billion operational capital in 2011

    Life IRR of at least 12% with payback of 10 years or less

    2011 general insurance COR of 97% or better

    Additional cost savings of 200 million and 200 million efficiency gains by 2012

    A clear strategy

    Increase focus and depth in 12 countries

    Excelling in Life & GI, driving out composite value

    1. A strong customer base, with a growing franchise

    2. Tight cost control

    3. A strong balance sheet

    Valuation upside

    Dividend yield of over 5.5%

    Valued at only 8.5x IFRS earnings

    Trading on only 70% of EEV NAV

    3

  • 8/7/2019 Aviva UK: Morgan Stanley European Financials Conference, March 2011

    4/17

    4

    Significant growth in all key performance metrics

    IFRSoperating profit

    Net operatingcapital generated

    FY10

    1.0bn

    1.7bn

    FY09FY10FY09

    2,550m

    2,022m

    NAV

    IFRS

    EEV374p

    621p

    FY10FY09

    IFRS

    454p

    FY10

    Dividend

    25.5p

    FY10FY09

    6%24p

    IFRS Return on Equity

    FY10

    10.9%

    14.8%

    FY09

    26%70%

    80p

    Funds under management

    402bn

    FY10FY09

    23bn379bn

  • 8/7/2019 Aviva UK: Morgan Stanley European Financials Conference, March 2011

    5/17

    5

    Strong growth in Life & GI

    Life IRR

    10.0%

    12.5%2.5ppt

    FY10FY09

    Life sales (PVNBP)

    33.4bn

    32.0bn4%

    FY10FY09

    Life operating profit

    1,887m

    2,318m

    23%

    FY10FY09

    GI & Health sales (NWP)

    9.2bn

    9.7bn

    GI COR

    99%

    97%6%

    FY10FY09 FY10FY09

    960m

    GI & Health operating profit

    1,050m

    FY10FY09

    9%

  • 8/7/2019 Aviva UK: Morgan Stanley European Financials Conference, March 2011

    6/17

    Growing income whilst controlling expenses

    6

    Expenses

    Income

    m

  • 8/7/2019 Aviva UK: Morgan Stanley European Financials Conference, March 2011

    7/17

    Strong profit growth vs competitors

    7

    66%

    26% 24%

    22%17%

    7%5%

    (13%)

    (18%)

    (10%)

    Aegon Aviva Prudential ING** Allianz StandardLife

    AxaZurich RSAL&G

    2010 growth in IFRS operating profit*

    12%

    Generali

    * Year on year growth in operating profit or underlying earnings before tax and minority interests at reported exchange rates** ING insurance operations only

  • 8/7/2019 Aviva UK: Morgan Stanley European Financials Conference, March 2011

    8/17

    A clear strategy

    Delivering against the targets

    8

  • 8/7/2019 Aviva UK: Morgan Stanley European Financials Conference, March 2011

    9/17

    Continued growth in third party assets

    Focus on growing franchise value

    Focus on growing profits organically

    Hold for value

    Invest and deepen presence inpriority markets 5 plus 2

    Invest and deepen presence

    DeltaLloyd

    NorthAmerica

    AsiaPacific

    AvivaInvestors

    Europe

    UK

    Gross capitalgeneration

    IFRS operatingprofit contribution

    0.91.4

    0.80.9

    0.4*0.5

    0.60.4

    --

    -0.1

    Strategic direction

    9

    FY 2010 (bn)

    Strategy: Increasing focus & depthin our chosen countries

    * Excluding Delta Lloyd longevity reserving of 0.2 billion post tax & MI

  • 8/7/2019 Aviva UK: Morgan Stanley European Financials Conference, March 2011

    10/17

    A strong life customer base with a growing franchise

    10

    bn

    33bn

    36bn

    FY10FY09

    Increased future life cash flows Increasing life IFRS operating profit

  • 8/7/2019 Aviva UK: Morgan Stanley European Financials Conference, March 2011

    11/17

    11

    m

    FY10FY09

    9%960m

    1,050m

    Rolling 12 month GI & Health net written premiums GI & Health operating profit

    A strong GI customer base with a growing franchise

  • 8/7/2019 Aviva UK: Morgan Stanley European Financials Conference, March 2011

    12/17

    4%

    11%

    63%

    39%

    33%

    10%

    29%

    20%

    0%

    10%

    20%

    30%

    40%

    50%

    60%

    70%

    Dec '08 Q1 2009 Q2 2009 Q3 2009 Q4 2009 Q1 2010 Q2 2010 Q3 2010 Q4 2010

    53%

    55% Direct Line

    29% Scottish Widows

    16% Standard Life17% Legal & General

    27% Prudential26% More Than

    13% Esure

    Growing the franchiseAviva brand awareness in the UK

    YouGov Brand Index data a Nationally representative daily sample of over 2000 people

    12

  • 8/7/2019 Aviva UK: Morgan Stanley European Financials Conference, March 2011

    13/17

    Tight cost control

    13% reduction in costs since 2008

    500 million cost savings achieved and more to come

    13

    m

  • 8/7/2019 Aviva UK: Morgan Stanley European Financials Conference, March 2011

    14/17

    A strong balance sheet: asset & liability matchingensures predictable in-force earnings

    14

    Clear benefits of asset and liabilityduration matching at point of sale

    21.0bn

    Assets and liabilities are well matched

    Duration in years (HY 2010)

    Shareholderfunds

    31bn 15.8bn0.8bn

    Limited guarantee risk

    Limited impact from interest ratemovements

    Assets held to maturity

    Track record of minimal defaults

  • 8/7/2019 Aviva UK: Morgan Stanley European Financials Conference, March 2011

    15/17

    A strong balance sheet: further progress in 2010with the reduction of the pension scheme deficit

    15

    Actions Result (bn)

    1.7

    ZeroPensionschemeaccounting

    basisdeficit(bn)

    0.3 0.6

    0.3

    0.4

    0.2

    0.5

    Aviva and RAC schemes closed reducingliabilities

    Aviva scheme

    Long-term funding agreement in place

    378 million deficit funding paymentin 2010

    Updated mortality assumptions favourablein the UK with offset in DL

    Ongoing further ALM improvements andvolatility mitigation strategies underway-

    covering longevity, equity, interest rate,inflation and credit exposure

  • 8/7/2019 Aviva UK: Morgan Stanley European Financials Conference, March 2011

    16/17

    Delivering against the targets:remaining fully focused on financial commitments

    16

    Deliver at least 1.5 billion operationalcapital in 2011

    2011 general insurance COR to be 97%or better

    Deliver a Life IRR of at least 12% withpayback of 10 years or less

    Additional cost savings of 200 millionand a further 200 million efficiency

    gains by end 2012

    1.7 billion operational capitalgenerated in 2010,

    a 70% increase on 2009

    97% COR delivered in 2010

    Life IRR of 12.5% delivered in 2010 witha payback period averaging 8 years

    Original 500 million target achievedone year early in 2009

    Track recordTarget

  • 8/7/2019 Aviva UK: Morgan Stanley European Financials Conference, March 2011

    17/17

    Resilient & diversified with growing earnings

    Delivering against the targets

    At least 1.5 billion operational capital in 2011

    Life IRR of at least 12% with payback of 10 years or less

    2011 general insurance COR of 97% or better

    Additional cost savings of 200 million and 200 million efficiency gains by 2012

    A clear strategy

    Increase focus and depth in 12 countries

    Excelling in Life & GI, driving out composite value

    1. A strong customer base, with a growing franchise

    2. Tight cost control

    3. A strong balance sheet

    Valuation upside

    Dividend yield of over 5.5%

    Valued at only 8.5x IFRS earnings

    Trading on only 70% of EEV NAV

    17